InvestorsHub Logo
Followers 2
Posts 735
Boards Moderated 0
Alias Born 04/08/2004

Re: squittman post# 12228

Monday, 06/24/2013 10:00:23 AM

Monday, June 24, 2013 10:00:23 AM

Post# of 12383
ummm... sounds a little reminiscent of another "cure" story published in the media about 15 years ago... this again is a pre-clinical trial in mice... there has yet to be a peer review or publication in a scientific journal... ...and the information coming out is from the popular media, not scientific journals... the use of the phrase "sharp shooter" is indicative of this...

The patent is owned by the Toronto University Health Network and their are eight inventors listed including Dr. Mak... according to Mak, it took $40M to develop which was accumulated, mostly, from donors.

There is some skepticism among some scientists because the compound is effectively an RNA inhibitor which poses many problems in development and administration...

And again, as we have painfully learned before,there is often a non-bridgeable gap between a mouse and man...

It may be that they are on to something, but there is much yet to be proven...